NAME: ________________________

Question Types

Start With

Question Limit

of 60 available terms

Advertisement Upgrade to remove ads

5 Written Questions

5 Matching Questions

  1. 2424.01
  2. 2410
  3. 2427
  4. 2421.01
  5. 2422.02
  1. a Application Affected

    The sequence rules require the use of standard symbols and a standard format for sequence data in most sequence-type patent applications. They further require the submission of that data in computer readable form. Compliance is required for most disclosures of sequence data in new applications filed on or after October 1, 1990.
  2. b Furnishing of Samples
  3. c Form Paragraphs and Notice to Comply
  4. d Informational Requirements for the Sequence Listing
  5. e The Requirement for Exclusive Conformance; Sequences Presented in Drawing Figures

5 Multiple Choice Questions

  1. Possible Loss of U.S. Filing Date in Other Countries

    caution that in many countries the deposit must be made before the filing date of the priority application in order to obtain foreign priority rights.
  2. The Requirements for a Sequence Listing and Sequence Identifiers; Sequence Embeded in Application Text; Variants of a Presented Sequence
  3. Biological Material That Is Known and Readily Available to the Public
  4. Plant Material

    A deposit is not necessary for the grant of a plant patent under the provisions of 35 U.S.C. 161- 164. As with other biological material deposited for purposes of patents for inventions under 35 U.S.C. 101, the deposit of plant material together with the written specification must enable those skilled in the art to make and use the claimed invention, in accordance with the requirements of 35 U.S.C. 112.
  5. Requirement for Statement Regarding Content of Official and Computer Readable Copies of Sequence Listing

5 True/False Questions

  1. 2407.05Replacement May Not Be Recognized


  2. 2422.04The Requirement for a Computer Readable Copy of the Offical Copy of the Sequence Listing


  3. 2406.01Description in Application Specification
    37 CFR 1.804(a)
    requirement for a specific identification consistent with the description requirement of the first paragraph of 35 U.S.C. 112 and provides an antecedent basis for the biological material which either has been or will be deposited before the patent is granted.


  4. 2402Time of Making an Original Deposit


  5. 2407.04Treatment of Replacement
    37 CFR 1.805(e)
    where a replacement deposit is permitted and made, the examiner will assume that the same material as described in the patent is accessible from the identified depository unless evidence to the contrary comes to the attention of the Office


Create Set